- Home
- PMM vs NAUT Comparison
PMM vs NAUT Comparison
Compare PMM & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMM
- NAUT
- Stock Information
- Founded
- PMM 1989
- NAUT 2016
- Country
- PMM United States
- NAUT United States
- Employees
- PMM N/A
- NAUT N/A
- Industry
- PMM Investment Managers
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- PMM Finance
- NAUT Industrials
- Exchange
- PMM Nasdaq
- NAUT Nasdaq
- Market Cap
- PMM 276.7M
- NAUT 284.7M
- IPO Year
- PMM N/A
- NAUT N/A
- Fundamental
- Price
- PMM $6.05
- NAUT $1.73
- Analyst Decision
- PMM
- NAUT Hold
- Analyst Count
- PMM 0
- NAUT 3
- Target Price
- PMM N/A
- NAUT $3.58
- AVG Volume (30 Days)
- PMM 118.3K
- NAUT 180.7K
- Earning Date
- PMM 01-01-0001
- NAUT 10-29-2024
- Dividend Yield
- PMM 4.68%
- NAUT N/A
- EPS Growth
- PMM N/A
- NAUT N/A
- EPS
- PMM 0.23
- NAUT N/A
- Revenue
- PMM N/A
- NAUT N/A
- Revenue This Year
- PMM N/A
- NAUT N/A
- Revenue Next Year
- PMM N/A
- NAUT N/A
- P/E Ratio
- PMM $26.52
- NAUT N/A
- Revenue Growth
- PMM N/A
- NAUT N/A
- 52 Week Low
- PMM $5.00
- NAUT $1.65
- 52 Week High
- PMM $6.42
- NAUT $3.46
- Technical
- Relative Strength Index (RSI)
- PMM 31.28
- NAUT 30.18
- Support Level
- PMM $6.02
- NAUT $1.65
- Resistance Level
- PMM $6.43
- NAUT $2.10
- Average True Range (ATR)
- PMM 0.09
- NAUT 0.16
- MACD
- PMM -0.03
- NAUT -0.02
- Stochastic Oscillator
- PMM 7.32
- NAUT 13.05
About PMM Putnam Managed Municipal Income Trust
Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.